GuariguataL, WhitingDR, HambletonI, et al.: Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract, 2014; 103:137–149.
2.
International Diabetes Federation: IDF Diabetes Atlas Update Poster, 6th ed. Brussels: International Diabetes Federation, 2014.
3.
ChanJN, MalikV, JiaW, et al.: Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA, 2009; 301:2129–2140.
4.
TillinT, SattarN, GodslandIF, et al.: Ethnicity-specific obesity cut-points in the development of type 2 diabetes—a prospective study including three ethnic groups in the United Kingdom. Diabet Med, 2015; 32:226–234.
5.
AlmajwalAM, Al-BaghliNA, BatterhamMJ, et al.: Performance of body mass index in predicting diabetes and hypertension in the eastern province of Saudi Arabia. Ann Saudi Med, 2009; 29:437–445.
6.
Al-LawatiJA, BarakatNM, Al-LawatiAM, et al.: Optimal cut-points for body mass index, waist circumference and waist-to-hip ratio using the Framingham coronary heart disease risk score in an Arab population of the Middle East. Diabetes Vasc Dis Res, 2008; 5:304–309.
7.
SolliO, StavemK, KristiansenIS: Health-related quality of life in diabetes: the associations of complications with EQ-5D scores. Health Qual Life Outcomes, 2010; 8:18.
8.
WangW, FuCW, PanCY, et al.: How do type 2 diabetes mellitus-related chronic complications impact direct medical cost in four major cities of urban China?. Value Health, 2009; 12:923–929.
9.
TharkarS, DevarajanA, KumpatlaS, et al.: The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diab Res Clin Pract, 2010; 89:334–340.
10.
SpijkermanAMW, DekkerJM, NijpelsG, et al.: Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice. Diabetes Care, 2003; 26:2604–2608.
11.
SathishT, KannanS, SarmaSP, et al.: Screening performance of diabetes risk scores among Asians and whites in rural Kerala, India. Prev Chronic Dis, 2012; 10:E37.
12.
ZhangL, ZhangZ, ZhangY, et al.: Evaluation of Finnish diabetes risk score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999–2010. PloS One, 2014; 9:e97865.
13.
Al-LawatiJA, TuomilehtoJ: Diabetes risk score In Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract, 2007; 77:438–444.
14.
Al KhalafMM, EidMM, NajjarHA, et al.: Screening for diabetes in Kuwait and evaluation of risk scores. East Mediterr Health J, 2010; 16:725–731.
15.
MemishZA, ChangJL, SaeediMY, et al.: Screening for type 2 diabetes and dysglycemia in Saudi Arabia: development and validation of risk scores. Diabetes Technol Ther, 2015; 17:69–700.
16.
BasuS, MillettC, VijanS, et al.: The health system and population health implications of large-scale diabetes screening in India: a microsimulation model of alternative approaches. PloS Med, 2015; 12:e1001827.
17.
SherwinRS, AndersonRM, BuseJB, et al.: Prevention or delay of type 2 diabetes. Diabetes Care, 2004; 27(Suppl 1):S47–S54.
18.
NobleD, MathurR, DentT, et al.: Risk models and scores for type 2 diabetes: systematic review. BMJ, 2011; 343:d7163.
19.
MoonsKGM, AltmanDG, VergouweY, et al.: Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ, 2009; 338:b606.
